ArticleAdvances in therapy2024

Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings.

Paul Muntner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.